Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Nutraceutical Clinical Laboratories International, Inc., Secures $2 Million in Funding
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- FDA Requests Recall of Xiadafil VIP Tabs
The U.S. Food and Drug Administration today requested that SEI Pharmaceuticals, of Miami, Fla., recall all Xiadafil VIP Tabs sold in 8 tablet bottles (Lot # 6K029) or blister cards of 2 tablets (Lot # 6K029-SEI) because these products contain a potentially harmful, undeclared ingredient that may dangerously affect a person's blood pressure and can cause other life-threatening side effects. Xiadafil VIP Tabs are marketed as a dietary supplement for sexual enhancement and able to treat erectile dysfunction (ED).
- FDA Requests Recall of Xiadafil VIP Tabs
The U.S. Food and Drug Administration today requested that SEI Pharmaceuticals, of Miami, Fla., recall all Xiadafil VIP Tabs sold in 8 tablet bottles (Lot # 6K029) or blister cards of 2 tablets (Lot # 6K029-SEI) because these products contain a potentially harmful, undeclared ingredient that may dangerously affect a person's blood pressure and can cause other life-threatening side effects. Xiadafil VIP Tabs are marketed as a dietary supplement for sexual enhancement and able to treat erectile dysfunction (ED).
- FDA Requests Recall of Xiadafil VIP Tabs
The U.S. Food and Drug Administration today requested that SEI Pharmaceuticals, of Miami, Fla., recall all Xiadafil VIP Tabs sold in 8 tablet bottles (Lot # 6K029) or blister cards of 2 tablets (Lot # 6K029-SEI) because these products contain a potentially harmful, undeclared ingredient that may dangerously affect a person's blood pressure and can cause other life-threatening side effects. Xiadafil VIP Tabs are marketed as a dietary supplement for sexual enhancement and able to treat erectile dysfunction (ED).
- InterHealth Nutraceuticals Opposes Recent Petition to FDA to Treat Weight Loss Claims as Disease Claims
GlaxoSmithKline (NYSE: GSK) filed a joint citizen’s petition on April 22, 2008, which asked the Food and Drug Administration (FDA) to treat weight loss claims for dietary supplements as disease claims. InterHealth Nutraceuticals, other highly reputable manufacturers, and leading industry associations oppose the petition.
- InterHealth Nutraceuticals Opposes Recent Petition to FDA to Treat Weight Loss Claims as Disease Claims
GlaxoSmithKline (NYSE: GSK) filed a joint citizen’s petition on April 22, 2008, which asked the Food and Drug Administration (FDA) to treat weight loss claims for dietary supplements as disease claims. InterHealth Nutraceuticals, other highly reputable manufacturers, and leading industry associations oppose the petition.
- InterHealth Nutraceuticals Opposes Recent Petition to FDA to Treat Weight Loss Claims as Disease Claims
GlaxoSmithKline (NYSE: GSK) filed a joint citizen’s petition on April 22, 2008, which asked the Food and Drug Administration (FDA) to treat weight loss claims for dietary supplements as disease claims. InterHealth Nutraceuticals, other highly reputable manufacturers, and leading industry associations oppose the petition.
- InterHealth Nutraceuticals Opposes Recent Petition to FDA to Treat Weight Loss Claims as Disease Claims
GlaxoSmithKline (NYSE: GSK) filed a joint citizen’s petition on April 22, 2008, which asked the Food and Drug Administration (FDA) to treat weight loss claims for dietary supplements as disease claims. InterHealth Nutraceuticals, other highly reputable manufacturers, and leading industry associations oppose the petition.
- CHFA Comments on Health Canada’s Ten Year Plan to Strengthen Health Care in Canada
Yesterday, the Canadian Health Food Association (CHFA) appeared before the House of Commons Standing Committee on Health with respect to their study on the statutory review of the 10 Year Plan to Strengthen Health Care.
- CHFA Comments on Health Canada’s Ten Year Plan to Strengthen Health Care in Canada
Yesterday, the Canadian Health Food Association (CHFA) appeared before the House of Commons Standing Committee on Health with respect to their study on the statutory review of the 10 Year Plan to Strengthen Health Care.
- CHFA Comments on Health Canada’s Ten Year Plan to Strengthen Health Care in Canada
Yesterday, the Canadian Health Food Association (CHFA) appeared before the House of Commons Standing Committee on Health with respect to their study on the statutory review of the 10 Year Plan to Strengthen Health Care.
- International Pharmaceuticals, Ltd. Issues a Voluntary Recall of all Viril-Ity-Power (VIP) Tabs, a Product Marketed as a Dietary Supplement
International Pharmaceuticals, Ltd. has announced that it is conducting a voluntary recall of all the company’s supplement product sold under the brand name of Viril-Ity-Power (VIP) Tabs, 560mg/serving, after being informed by representatives of the Food and Drug Administration (FDA) that lab analysis by FDA of a sample from one lot of the product revealed that it contained a potentially harmful undeclared ingredient, hydroxyhomosildenafil.
- International Pharmaceuticals, Ltd. Issues a Voluntary Recall of all Viril-Ity-Power (VIP) Tabs, a Product Marketed as a Dietary Supplement
International Pharmaceuticals, Ltd. has announced that it is conducting a voluntary recall of all the company’s supplement product sold under the brand name of Viril-Ity-Power (VIP) Tabs, 560mg/serving, after being informed by representatives of the Food and Drug Administration (FDA) that lab analysis by FDA of a sample from one lot of the product revealed that it contained a potentially harmful undeclared ingredient, hydroxyhomosildenafil.
- International Pharmaceuticals, Ltd. Issues a Voluntary Recall of all Viril-Ity-Power (VIP) Tabs, a Product Marketed as a Dietary Supplement
International Pharmaceuticals, Ltd. has announced that it is conducting a voluntary recall of all the company’s supplement product sold under the brand name of Viril-Ity-Power (VIP) Tabs, 560mg/serving, after being informed by representatives of the Food and Drug Administration (FDA) that lab analysis by FDA of a sample from one lot of the product revealed that it contained a potentially harmful undeclared ingredient, hydroxyhomosildenafil.
- International Pharmaceuticals, Ltd. Issues a Voluntary Recall of all Viril-Ity-Power (VIP) Tabs, a Product Marketed as a Dietary Supplement
International Pharmaceuticals, Ltd. has announced that it is conducting a voluntary recall of all the company’s supplement product sold under the brand name of Viril-Ity-Power (VIP) Tabs, 560mg/serving, after being informed by representatives of the Food and Drug Administration (FDA) that lab analysis by FDA of a sample from one lot of the product revealed that it contained a potentially harmful undeclared ingredient, hydroxyhomosildenafil.
- Workshop highlights dietary supplement regulation in Mexico
More than 100 Mexican and European Union (EU) regulators and experts came together at a workshop on May 6, to discuss and debate issues from the definition of food supplements and the criteria for setting maximum levels of vitamins and minerals, to the use of nutrition and health claims.
- Workshop highlights dietary supplement regulation in Mexico
More than 100 Mexican and European Union (EU) regulators and experts came together at a workshop on May 6, to discuss and debate issues from the definition of food supplements and the criteria for setting maximum levels of vitamins and minerals, to the use of nutrition and health claims.
- NSF International to Host Special Dietary Supplement GMP Training in China
To assist manufacturers and distributors in China with the implementation of the new regulations, NSF today announced that it will be holding a special Good Manufacturing Practices (GMP) training seminar for the dietary supplement industry, Tuesday, June 24th, 2008 from 9:00 AM - 5:00 PM at NSF’s Shanghai Office.
- NSF International to Host Special Dietary Supplement GMP Training in China
To assist manufacturers and distributors in China with the implementation of the new regulations, NSF today announced that it will be holding a special Good Manufacturing Practices (GMP) training seminar for the dietary supplement industry, Tuesday, June 24th, 2008 from 9:00 AM - 5:00 PM at NSF’s Shanghai Office.
- NSF International to Host Special Dietary Supplement GMP Training in China
To assist manufacturers and distributors in China with the implementation of the new regulations, NSF today announced that it will be holding a special Good Manufacturing Practices (GMP) training seminar for the dietary supplement industry, Tuesday, June 24th, 2008 from 9:00 AM - 5:00 PM at NSF’s Shanghai Office.
- NSF International to Host Special Dietary Supplement GMP Training in China
To assist manufacturers and distributors in China with the implementation of the new regulations, NSF today announced that it will be holding a special Good Manufacturing Practices (GMP) training seminar for the dietary supplement industry, Tuesday, June 24th, 2008 from 9:00 AM - 5:00 PM at NSF’s Shanghai Office.
- NSF International to Host Special Dietary Supplement GMP Training in China
To assist manufacturers and distributors in China with the implementation of the new regulations, NSF today announced that it will be holding a special Good Manufacturing Practices (GMP) training seminar for the dietary supplement industry, Tuesday, June 24th, 2008 from 9:00 AM - 5:00 PM at NSF’s Shanghai Office.
- EAS highlights claims regulations across the globe
Companies and regulators from Asia’s food and nutrition sector met in Singapore this week for an informative tour including a seminar, Tuesday June 10 at the Singapore Management University, of nutrition and health claims regulations in Asia, the European Union (EU) and the United States (US).
- EAS highlights claims regulations across the globe
Companies and regulators from Asia’s food and nutrition sector met in Singapore this week for an informative tour including a seminar, Tuesday June 10 at the Singapore Management University, of nutrition and health claims regulations in Asia, the European Union (EU) and the United States (US).
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- More TRAACS(TM) from Albion Approved by the EU
The EFSA (European Food Safety Authority) has listed its summary of opinion on four more of Albion’s bisglycinate chelates: calcium, magnesium zinc, and copper. At the request of the European Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked to deliver a scientific opinion on these four mineral bisglycinates produced by Albion, and the opinion was a positive one.
- CHFA Applauds Government for Listening to Industry’s Concerns
the Canadian Health Food Association (CHFA) is applauding the government for listening to the natural products (NHP) industry’s concerns regarding Bill C-51, an Act to amend the Food and Drugs Act and to make consequential amendments to other Acts, and subsequently tabling amendments which would place NHPs in a separate category in the proposed legislation.
- CHFA Applauds Government for Listening to Industry’s Concerns
the Canadian Health Food Association (CHFA) is applauding the government for listening to the natural products (NHP) industry’s concerns regarding Bill C-51, an Act to amend the Food and Drugs Act and to make consequential amendments to other Acts, and subsequently tabling amendments which would place NHPs in a separate category in the proposed legislation.
- CHFA Applauds Government for Listening to Industry’s Concerns
the Canadian Health Food Association (CHFA) is applauding the government for listening to the natural products (NHP) industry’s concerns regarding Bill C-51, an Act to amend the Food and Drugs Act and to make consequential amendments to other Acts, and subsequently tabling amendments which would place NHPs in a separate category in the proposed legislation.
- FDA Warns Individuals and Firms to Stop Selling Fake Cancer 'Cures'
Warning Letters have been sent to 23 U.S. companies and two foreign individuals marketing a wide range of products fraudulently claiming to prevent and cure cancer, according to the U.S. Food and Drug Administration.
- FDA Warns Individuals and Firms to Stop Selling Fake Cancer 'Cures'
Warning Letters have been sent to 23 U.S. companies and two foreign individuals marketing a wide range of products fraudulently claiming to prevent and cure cancer, according to the U.S. Food and Drug Administration.
- FDA Warns Individuals and Firms to Stop Selling Fake Cancer 'Cures'
Warning Letters have been sent to 23 U.S. companies and two foreign individuals marketing a wide range of products fraudulently claiming to prevent and cure cancer, according to the U.S. Food and Drug Administration.
- United States and China Outline Progress on Agreement on Food and Feed Safety
U.S. Secretary of Health and Human Services (HHS) Mike Leavitt signed a Joint Progress Statement today with the Honorable Li Changjiang, Minister of the General Administration of Quality Supervision, Inspection, and Quarantine (AQSIQ) of the People’s Republic of China. The document outlines steps taken by both nations in implementing the 2007 Memorandum of Agreement (MOA) on food and feed safety.
- United States and China Outline Progress on Agreement on Food and Feed Safety
U.S. Secretary of Health and Human Services (HHS) Mike Leavitt signed a Joint Progress Statement today with the Honorable Li Changjiang, Minister of the General Administration of Quality Supervision, Inspection, and Quarantine (AQSIQ) of the People’s Republic of China. The document outlines steps taken by both nations in implementing the 2007 Memorandum of Agreement (MOA) on food and feed safety.
- United States and China Outline Progress on Agreement on Food and Feed Safety
U.S. Secretary of Health and Human Services (HHS) Mike Leavitt signed a Joint Progress Statement today with the Honorable Li Changjiang, Minister of the General Administration of Quality Supervision, Inspection, and Quarantine (AQSIQ) of the People’s Republic of China. The document outlines steps taken by both nations in implementing the 2007 Memorandum of Agreement (MOA) on food and feed safety.
- United States and Viet Nam Sign Agreement on the Safety of Food, Medical Products
The United States and the Socialist Republic of Viet Nam today signed a memorandum of understanding (MOU) to enhance the safety of food, feed, drugs and medical devices traded between the two nations.
- United States and Viet Nam Sign Agreement on the Safety of Food, Medical Products
The United States and the Socialist Republic of Viet Nam today signed a memorandum of understanding (MOU) to enhance the safety of food, feed, drugs and medical devices traded between the two nations.
- United States and Viet Nam Sign Agreement on the Safety of Food, Medical Products
The United States and the Socialist Republic of Viet Nam today signed a memorandum of understanding (MOU) to enhance the safety of food, feed, drugs and medical devices traded between the two nations.
- Native Essence Herb Company Sues FTC
The Federal Trade Commission is being sued over the use of history. A New Mexico herb company says the First Amendment gives it the right to tell customers the historical use of herbs in treating serious diseases. The FTC says this violates its guidelines.
- Native Essence Herb Company Sues FTC
The Federal Trade Commission is being sued over the use of history. A New Mexico herb company says the First Amendment gives it the right to tell customers the historical use of herbs in treating serious diseases. The FTC says this violates its guidelines.
- Seminar looks to global TMHS regulations for ASEAN model
More than 200 people including regulators, academics and industry representatives attended a seminar in Malaysia this month to discuss regional and global developments on Traditional Medicines and Health Supplements (TMHS). Held on June 4, the seminar focused on the harmonisation process for TMHS within the Association of South East Asian Nations (ASEAN), offering representatives the opportunity to learn about other regulatory systems against which the emerging ASEAN model could be benchmarked.
- Seminar looks to global TMHS regulations for ASEAN model
More than 200 people including regulators, academics and industry representatives attended a seminar in Malaysia this month to discuss regional and global developments on Traditional Medicines and Health Supplements (TMHS). Held on June 4, the seminar focused on the harmonisation process for TMHS within the Association of South East Asian Nations (ASEAN), offering representatives the opportunity to learn about other regulatory systems against which the emerging ASEAN model could be benchmarked.
- Claims substantiation criteria too strict for SMEs says EBF
Scientists may be applying too strict criteria for the substantiation of article 13 health claims that will disadvantage small businesses, the European Botanical Forum (EBF) has said.
- Claims substantiation criteria too strict for SMEs says EBF
Scientists may be applying too strict criteria for the substantiation of article 13 health claims that will disadvantage small businesses, the European Botanical Forum (EBF) has said.
- Claims substantiation criteria too strict for SMEs says EBF
Scientists may be applying too strict criteria for the substantiation of article 13 health claims that will disadvantage small businesses, the European Botanical Forum (EBF) has said.
- Claims substantiation criteria too strict for SMEs says EBF
Scientists may be applying too strict criteria for the substantiation of article 13 health claims that will disadvantage small businesses, the European Botanical Forum (EBF) has said.
- Claims substantiation criteria too strict for SMEs says EBF
Scientists may be applying too strict criteria for the substantiation of article 13 health claims that will disadvantage small businesses, the European Botanical Forum (EBF) has said.
- Algatechnologies Expands its Regulatory Approvals for Astaxanthin in Europe
Algatechnologies, Israel, has been given a green light to market its AstaPure®, natural astaxanthin line for dietary supplements in Europe. The UK Foods Standards Agency (FSA) approved the product under European novel foods legislations.
- Algatechnologies Expands its Regulatory Approvals for Astaxanthin in Europe
Algatechnologies, Israel, has been given a green light to market its AstaPure®, natural astaxanthin line for dietary supplements in Europe. The UK Foods Standards Agency (FSA) approved the product under European novel foods legislations.
- Algatechnologies Expands its Regulatory Approvals for Astaxanthin in Europe
Algatechnologies, Israel, has been given a green light to market its AstaPure®, natural astaxanthin line for dietary supplements in Europe. The UK Foods Standards Agency (FSA) approved the product under European novel foods legislations.
- Algatechnologies Expands its Regulatory Approvals for Astaxanthin in Europe
Algatechnologies, Israel, has been given a green light to market its AstaPure®, natural astaxanthin line for dietary supplements in Europe. The UK Foods Standards Agency (FSA) approved the product under European novel foods legislations.
- Algatechnologies Expands its Regulatory Approvals for Astaxanthin in Europe
Algatechnologies, Israel, has been given a green light to market its AstaPure®, natural astaxanthin line for dietary supplements in Europe. The UK Foods Standards Agency (FSA) approved the product under European novel foods legislations.
- Algatechnologies Expands its Regulatory Approvals for Astaxanthin in Europe
Algatechnologies, Israel, has been given a green light to market its AstaPure®, natural astaxanthin line for dietary supplements in Europe. The UK Foods Standards Agency (FSA) approved the product under European novel foods legislations.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- EAS develops guide to marketing nutritional products in Asia
Food and nutrition policy consultancy EAS will release its latest publication next month – an easy-to-follow regulatory guide to help companies launch nutritional products in 10 Asian markets.
- New Head for Food Standards Australia New Zealand Board
A former Commonwealth Ombudsman, Philippa Smith AM, has been appointed as Chair of the Food Standards Australia New Zealand (FSANZ) board.
- New Head for Food Standards Australia New Zealand Board
A former Commonwealth Ombudsman, Philippa Smith AM, has been appointed as Chair of the Food Standards Australia New Zealand (FSANZ) board.
- New Head for Food Standards Australia New Zealand Board
A former Commonwealth Ombudsman, Philippa Smith AM, has been appointed as Chair of the Food Standards Australia New Zealand (FSANZ) board.
- New Head for Food Standards Australia New Zealand Board
A former Commonwealth Ombudsman, Philippa Smith AM, has been appointed as Chair of the Food Standards Australia New Zealand (FSANZ) board.
- Jack Distribution, LLC. Issues a Voluntary Nationwide Recall of Select Lots of Rize 2 The Occasion Capsules and Rose 4 Her Capsules, Products Marketed as Dietary Supplements, Containing an Undeclared Ingredient
Jack Distribution, LLC and its wholesale distributors G & N works, Inc., and Devine Distribution, Inc., have announced that they are conducting a voluntary nationwide recall of the following lot numbers of the company's supplement products sold under the brand names Rize 2 The Occasion and Rose 4 Her. (Rize 2 lot numbers CG-84 expires 11/10, GD-98 expires 08/10, CC-06 expires 06/10, 709 expires 09/10, CG-79 expires 11/10) (Rose 4 Her lot number CG-78 expires 11/10). FDA asserts that its chemical analysis revealed that these lots of Rize 2 The Occasion and Rose 4 Her contain thiomethisosildenafil, an analog of sildenafil, the active ingredient of a FDA-approved drug used for Erectile Dysfunction (ED).
- Jack Distribution, LLC. Issues a Voluntary Nationwide Recall of Select Lots of Rize 2 The Occasion Capsules and Rose 4 Her Capsules, Products Marketed as Dietary Supplements, Containing an Undeclared Ingredient
Jack Distribution, LLC and its wholesale distributors G & N works, Inc., and Devine Distribution, Inc., have announced that they are conducting a voluntary nationwide recall of the following lot numbers of the company's supplement products sold under the brand names Rize 2 The Occasion and Rose 4 Her. (Rize 2 lot numbers CG-84 expires 11/10, GD-98 expires 08/10, CC-06 expires 06/10, 709 expires 09/10, CG-79 expires 11/10) (Rose 4 Her lot number CG-78 expires 11/10). FDA asserts that its chemical analysis revealed that these lots of Rize 2 The Occasion and Rose 4 Her contain thiomethisosildenafil, an analog of sildenafil, the active ingredient of a FDA-approved drug used for Erectile Dysfunction (ED).
- Jack Distribution, LLC. Issues a Voluntary Nationwide Recall of Select Lots of Rize 2 The Occasion Capsules and Rose 4 Her Capsules, Products Marketed as Dietary Supplements, Containing an Undeclared Ingredient
Jack Distribution, LLC and its wholesale distributors G & N works, Inc., and Devine Distribution, Inc., have announced that they are conducting a voluntary nationwide recall of the following lot numbers of the company's supplement products sold under the brand names Rize 2 The Occasion and Rose 4 Her. (Rize 2 lot numbers CG-84 expires 11/10, GD-98 expires 08/10, CC-06 expires 06/10, 709 expires 09/10, CG-79 expires 11/10) (Rose 4 Her lot number CG-78 expires 11/10). FDA asserts that its chemical analysis revealed that these lots of Rize 2 The Occasion and Rose 4 Her contain thiomethisosildenafil, an analog of sildenafil, the active ingredient of a FDA-approved drug used for Erectile Dysfunction (ED).
- Jack Distribution, LLC. Issues a Voluntary Nationwide Recall of Select Lots of Rize 2 The Occasion Capsules and Rose 4 Her Capsules, Products Marketed as Dietary Supplements, Containing an Undeclared Ingredient
Jack Distribution, LLC and its wholesale distributors G & N works, Inc., and Devine Distribution, Inc., have announced that they are conducting a voluntary nationwide recall of the following lot numbers of the company's supplement products sold under the brand names Rize 2 The Occasion and Rose 4 Her. (Rize 2 lot numbers CG-84 expires 11/10, GD-98 expires 08/10, CC-06 expires 06/10, 709 expires 09/10, CG-79 expires 11/10) (Rose 4 Her lot number CG-78 expires 11/10). FDA asserts that its chemical analysis revealed that these lots of Rize 2 The Occasion and Rose 4 Her contain thiomethisosildenafil, an analog of sildenafil, the active ingredient of a FDA-approved drug used for Erectile Dysfunction (ED).
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
OTTAWA - Health Canada is warning consumers not to use the dietary supplements 6-OXO (4-androstene-3,6,17-trione) and 1-AD (1-androstenediol), or any other supplements containing the ingredients 4-androstene-3,6,17-trione or 1-androstenediol, due to potentially serious health risks such as seizures and blood clots in the brain that can lead to disability.
Both 6-OXO and 1-AD are manufactured by ErgoPharm / Proviant Technologies in Champaign, Illinois. They are promoted as dietary supplements for body building, and are not authorized for sale in Canada. Health Canada has received one domestic adverse reaction case report in which an individual with no known predisposing medical conditions developed seizures and blood clots in his brain, associated with the use of 6-OXO and 1-AD.
6-OXO, which contains the compound 4-androstene-3,6,17-trione, is an unauthorized natural health product in Canada. 1-AD contains 1-androstenediol, an anabolic steroid that is regulated as a controlled substance in Canada, meaning it should only be dispensed by prescription and used under the supervision of a health professional. While neither product is authorized for sale in Canada, Canadians can access them over the Internet or purchase them while travelling abroad. The above-mentioned Canadian adverse reaction case involved a consumer who purchased the products in the U.S. and brought them into Canada through personal importation.
Consumers using 6-OXO, 1-AD, or other supplements containing 4-androstene-3,6,17-trione or 1-androstenediol without a prescription, are advised to stop taking the products immediately and consult with a health care professional if they have health concerns. Health Canada is taking action to prevent further importation of 6-OXO and 1-AD into Canada.
Health Canada is also reminding consumers to be cautious regarding the purchase of health products over the Internet or from outside of Canada, as these products may not have been assessed to the same standards as products approved for sale on the Canadian market. Authorized health products will bear either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN), or a Homeopathic Drug Number (DIN-HM). This authorization indicates that the products have been assessed by Health Canada for safety, effectiveness and quality.
Consumers should contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find 6-OXO or 1-AD or any other supplements containing 4-androstene-3,6,17-trione, or 1-androstenediol being sold at a Canadian retail outlet without a prescription.
Consumers requiring more information about this warning can contact Health Canada's public enquiries line at (613) 957-2991, or toll free at 1-866-225-0709.
To report a suspected adverse reaction to these health products, please contact the Canada Vigilance Program of Health Canada by one of the following methods:
Telephone: 1-866-234-2345
Facsimile: 1-866-678-6789
Canada Vigilance Program
Marketed Health Products Directorate
Ottawa, Ontario, AL 0701C
K1A 0K9
E-mail: CanadaVigilance@hc-sc.gc.ca
The Canada Vigilance adverse reaction reporting form, including a version that can be completed and submitted online, is located in the MedEffect area of the Health Canada Web site.
- 30 - |